Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context
- 1 March 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 20 (3) , 1
Abstract
Background: Type 1 diabetes mellitus (T1D) is a chronic disease that requires exogenous insulin administration and intensive management to prevent any complications. Recent innovations in T1D management technologies include the Advanced Hybrid Closed-Loop delivery system (AHCL). The pioneer AHCL system provides automated basal and automated bolus corrections when needed Objective: This study aimed to compare the Advanced Hybrid Closed-Loop (AHCL) system and the Sensor-Augmented Pump (SAP) with Predictive Low Glucose Management (PLGM) system, in relation to glycaemic outcomes, general and diabetes-related Quality of Life (QoL), and diabetes distress. Methods: General and diabetes-related QoL were assessed with the Diabetes Quality of Life Brief Clinical Inventory (DQOL-BCI) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF), respectively. Diabetes distress was assessed with the Diabetes Distress Scale for Type 1 diabetes (T1-DDS). Results: Eighty-nine T1D adults participated in the study, mostly females (65.2%), with a mean age of 39.8 (± 11.5 years). They had on average 23 years of diabetes (± 10.7) and they were on continuous subcutaneous insulin infusion therapy. Significant differences favoring the AHCL over the SAP + PLGM system were demonstrated by lower mean glucose levels, less time above range, lower scores on DQOL-BCI, T1-DDS, and higher scores on WHOQOL-BREF. Finally, the linear regression models revealed the association of time in range in most of the above aspects. Conclusion: This study highlighted the advantages of the AHCL system over the SAP + PLGM system in the real-world setting in relation to general and diabetes-related QoL, diabetes distress, and glycaemic outcomes.Keywords
This publication has 38 references indexed in Scilit:
- Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS)Diabetes Research and Clinical Practice, 2019
- Measuring the reliability and validity of the Greek edition of the Diabetes Quality of Life Brief Clinical InventoryDiabetes Research and Clinical Practice, 2018
- Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorDiabetes Technology & Therapeutics, 2017
- Diabetes Distress Among Adolescents with Type 1 Diabetes: a Systematic ReviewCurrent Diabetes Reports, 2016
- Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizonsExpert Opinion on Drug Delivery, 2015
- Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient—An Evidence-based ApproachCurrent Diabetes Reports, 2015
- Understanding the sources of diabetes distress in adults with type 1 diabetesJournal of Diabetes and its Complications, 2015
- Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS studyActa Diabetologica, 2013
- From pumps to prevention: recent advances in the treatment of type 1 diabetesDrug Discovery Today, 2009
- Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injectionsDiabetic Medicine, 2008